Lista de obras -

2020 Updated Asthma Guidelines: Allergen immunotherapy

artículo científico publicado en 2020

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

article

Advances in upper airway diseases and allergen immunotherapy

artículo científico publicado en 2006

Advances in upper airway diseases and allergen immunotherapy

artículo científico publicado en 2003

Advances in upper airway diseases and allergen immunotherapy

scientific article published on 01 April 2004

Advances in upper airway diseases and allergen immunotherapy

artículo científico publicado en 2005

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles

artículo científico publicado en 2017

Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?

artículo científico publicado en 2017

Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient

artículo científico publicado en 2016

Allergen immunotherapy now and in the future

artículo científico publicado en 2016

Allergen immunotherapy: A practice parameter third update ⬇️

artículo científico publicado el 3 de diciembre de 2010

Allergen immunotherapy: a centenary celebration

artículo científico publicado en 2011

Allergen immunotherapy: what's new, what's next?

artículo científico publicado en 2015

Allergen immunotherapy: where is it now?

artículo científico publicado en 2007

Allergen-specific immunotherapy

artículo científico publicado en 2014

Allergy immunotherapy for inhalant allergens: Strategies to improve efficacy

scientific article published on 01 January 2020

Allergy immunotherapy for inhalant allergens: Strategies to minimize adverse reactions

artículo científico publicado en 2020

Allergy immunotherapy: Future directions for the 2020s

artículo científico publicado en 2020

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

artículo científico

Are meta-analysis-based comparisons solid evidence?

scientific article published on 20 June 2013

Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma

artículo científico publicado en 2003

Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys

artículo científico publicado en 2012

Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report

scientific article published on 15 May 2020

Combination therapy of long-acting beta agonists and inhaled corticosteroids in the management of chronic asthma

artículo científico publicado en 2005

Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist

artículo científico publicado en 2011

Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial

artículo científico publicado en 2008

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma

artículo científico publicado en 2010

Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial

scientific article published on 15 April 2020

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children.

artículo científico publicado en 2014

Efficacy and safety of allergen immunotherapy in children

artículo científico publicado en 2006

Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial

artículo científico publicado en 2013

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

artículo científico publicado en 2014

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis

artículo científico publicado en 2014

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

artículo científico publicado en 2011

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC).

artículo científico publicado en 2011

Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.

artículo científico publicado en 2016

Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study

artículo científico publicado en 2007

Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets

artículo científico publicado en 2016

Evaluation of a skin test device designed to be less painful

article by Harold S. Nelson et al published December 2012 in The Journal of Allergy and Clinical Immunology

Food and Drug Administration reclassification of allergens for diagnosis and treatment: now is the time to be heard

artículo científico publicado en 2012

History of specific immunotherapy

Immunologic response to administration of standardized dog allergen extract at differing doses.

artículo científico publicado en 2006

Immunotherapy coming of age: notable advances during the first hundred years

scientific article published on 15 February 2017

Immunotherapy for house-dust mite allergy

scientific article published on 01 July 2018

Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet

artículo científico publicado en 2018

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

artículo científico publicado en 2018

Is sublingual immunotherapy ready for use in the United States?

artículo científico publicado en 2013

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial

artículo científico

Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure.

artículo científico publicado en 2014

Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events

artículo científico publicado en 2008

Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop

scientific article published on 05 February 2019

Multiallergen immunotherapy for allergic rhinitis and asthma

artículo científico publicado en 2009

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy

artículo científico publicado en 2014

New forms of allergy immunotherapy for rhinitis and asthma

artículo científico

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

artículo científico publicado en 2015

Pain perception and performance of three devices for single-site allergen skin testing.

artículo científico publicado en 2014

Patient and physician perspectives on the attributes of nasal allergy medications

artículo científico publicado en 2007

Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents

artículo científico publicado en 2017

Preparing and mixing allergen vaccines for subcutaneous immunotherapy.

artículo científico publicado en 2008

Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis

artículo científico publicado en 2018

Recommendations for appropriate sublingual immunotherapy clinical trials

artículo científico publicado en 2009

Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract

artículo científico publicado en 2009

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

artículo científico publicado en 2016

SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration.

artículo científico publicado en 2018

Safety of long-acting beta-agonists in asthma: a review

artículo científico publicado en 2008

Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.

artículo científico publicado en 2016

Short ragweeds is highly cross-reactive with other ragweeds

artículo científico publicado en 2015

Short-term safety of somatropin inhalation powder in adults with mild to moderate asthma

artículo científico publicado en 2009

Skin testing: a survey of allergists

artículo científico publicado en 2006

Some highlights of the first century of immunotherapy

artículo científico

Specific immunotherapy with allergen mixes: what is the evidence?

artículo científico publicado en 2009

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

artículo científico publicado en 2009

Sub-lingual immunotherapy: world allergy organization position paper 2009.

artículo científico publicado en 2009

Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe

artículo científico publicado en 2016

Subcutaneous Injection Immunotherapy for Optimal Effectiveness ⬇️

artículo científico publicado el 1 de mayo de 2011

Subcutaneous immunotherapy

artículo científico publicado en 2011

Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?

artículo científico

Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma

artículo científico publicado en 2017

Sublingual immunotherapy: World Allergy Organization position paper 2013 update

artículo científico publicado en 2014

Sublingual immunotherapy: a comprehensive review.

artículo científico publicado en 2006

Sublingual immunotherapy: the U.S. experience

artículo científico

The Evolution of Allergy Immunotherapy

artículo científico publicado en 2020

The efficacy and safety of the Timothy grass allergy sublingual immunotherapy tablet in Canadian adults and children

artículo científico publicado en 2014

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses

artículo científico publicado en 2016

Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet

artículo científico

Unresponsive wheezing to asthma therapy in a 32-year-old female

artículo científico publicado en 2003

Update on allergy immunotherapy: American Academy of Allergy, Asthma & Immunology/European Academy of Allergy and Clinical Immunology/PRACTALL consensus report

artículo científico

Update on house dust mite immunotherapy: are more studies needed?

artículo científico

Update on the safety of long-acting beta-agonists in combination with inhaled corticosteroids for the treatment of asthma

artículo científico publicado en 2009

What will allergen immunotherapy look like in the future?

artículo científico publicado en 2012

Lista de obras de

2020 Updated Asthma Guidelines: Allergen immunotherapy

A double-blind, placebo-controlled immunotherapy dose-response study with standardized cat extract

Advances in upper airway diseases and allergen immunotherapy

Advances in upper airway diseases and allergen immunotherapy

Advances in upper airway diseases and allergen immunotherapy

Advances in upper airway diseases and allergen immunotherapy

Advances in upper airway diseases and allergen immunotherapy

Allergen Immunotherapy Clinical Trial Outcomes and Design: Working Toward Harmonization of Methods and Principles

Allergen Immunotherapy for a Teenager with Seasonal Allergic Rhinitis Due to Grass Pollen: Subcutaneous or Sublingual Route?

Allergen immunotherapy (AIT) for the multiple-pollen sensitive patient

Allergen immunotherapy now and in the future

Allergen immunotherapy: A practice parameter third update ⬇️

Allergen immunotherapy: a centenary celebration

Allergen immunotherapy: what's new, what's next?

Allergen immunotherapy: where is it now?

Allergen-specific immunotherapy

Allergy immunotherapy for inhalant allergens: Strategies to improve efficacy

Allergy immunotherapy for inhalant allergens: Strategies to minimize adverse reactions

Allergy immunotherapy: Future directions for the 2020s

An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.

Are meta-analysis-based comparisons solid evidence?

Budesonide Turbuhaler delivered once daily improves health-related quality of life and maintains improvements with a stepped-down dose in adults with mild to moderate asthma

Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys

Clinical Practice of Allergen Immunotherapy for Allergic Rhinoconjunctivitis and Asthma: An Expert Panel Report

Combination therapy of long-acting beta agonists and inhaled corticosteroids in the management of chronic asthma

Current standards and future directions in immunotherapy: perspectives on challenges and opportunities for the allergist

Daclizumab improves asthma control in patients with moderate to severe persistent asthma: a randomized, controlled trial

Effect of pretreatment with omalizumab on the tolerability of specific immunotherapy in allergic asthma

Efficacy and Safety of Ragweed SLIT-Tablet in Children with Allergic Rhinoconjunctivitis in a Randomized, Placebo-Controlled Trial

Efficacy and safety of MK-7243: a grass allergy sublingual immunotherapy tablet evaluated in Canadian adults and children.

Efficacy and safety of allergen immunotherapy in children

Efficacy and safety of grass sublingual immunotherapy tablet, MK-7243: a large randomized controlled trial

Efficacy and safety of ragweed sublingual immunotherapy in Canadian patients with allergic rhinoconjunctivitis

Efficacy and safety of standardized short ragweed sublingual immunotherapy tablet (SLIT-T) treatment in Canadian subjects with ragweed pollen-induced rhinitis with or without conjunctivitis

Efficacy and safety of timothy grass allergy immunotherapy tablet treatment in North American adults

Efficacy of Timothy grass allergy immunotherapy tablet (AIT) treatment in Canadian children and adults with grass pollen-induced allergic rhinoconjunctivitis (ARC).

Efficacy of house dust mite sublingual immunotherapy tablet in North American adolescents and adults in a randomized, placebo-controlled trial.

Efficacy of zileuton controlled-release tablets administered twice daily in the treatment of moderate persistent asthma: a 3-month randomized controlled study

Epinephrine Use in Clinical Trials of Sublingual Immunotherapy Tablets

Evaluation of a skin test device designed to be less painful

Food and Drug Administration reclassification of allergens for diagnosis and treatment: now is the time to be heard

History of specific immunotherapy

Immunologic response to administration of standardized dog allergen extract at differing doses.

Immunotherapy coming of age: notable advances during the first hundred years

Immunotherapy for house-dust mite allergy

Impact of Adverse Event Solicitation on the Safety Profile of SQ House Dust Mite Sublingual Immunotherapy Tablet

International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis

Is sublingual immunotherapy ready for use in the United States?

Long-term effects of a house dust mite sublingual immunotherapy tablet in an environmental exposure chamber trial

Magnitude of changes in patient symptom and medication scores in grass allergy immunotherapy trials: dependency on levels of pollen exposure.

Meta-analysis: effects of adding salmeterol to inhaled corticosteroids on serious asthma-related events

Mind the gaps: Clinical trial concepts to address unanswered questions in aeroallergen immunotherapy-An NIAID/AHRQ Workshop

Multiallergen immunotherapy for allergic rhinitis and asthma

Network meta-analysis shows commercialized subcutaneous and sublingual grass products have comparable efficacy

New forms of allergy immunotherapy for rhinitis and asthma

Onset and dose-related efficacy of house dust mite sublingual immunotherapy tablets in an environmental exposure chamber

Pain perception and performance of three devices for single-site allergen skin testing.

Patient and physician perspectives on the attributes of nasal allergy medications

Pooled efficacy and safety data for house dust mite sublingual immunotherapy tablets in adolescents

Preparing and mixing allergen vaccines for subcutaneous immunotherapy.

Ragweed allergy immunotherapy tablet MK-3641 (Ragwitek®) for the treatment of allergic rhinitis

Recommendations for appropriate sublingual immunotherapy clinical trials

Response to sublingual immunotherapy with grass pollen extract: monotherapy versus combination in a multiallergen extract

SQ grass sublingual allergy immunotherapy tablet for disease-modifying treatment of grass pollen allergic rhinoconjunctivitis.

SQ house dust mite sublingual immunotherapy tablet subgroup efficacy and local application site reaction duration.

Safety of long-acting beta-agonists in asthma: a review

Sequential Treatment Initiation with Timothy Grass and Ragweed Sublingual Immunotherapy Tablets Followed by Simultaneous Treatment Is Well Tolerated.

Short ragweeds is highly cross-reactive with other ragweeds

Short-term safety of somatropin inhalation powder in adults with mild to moderate asthma

Skin testing: a survey of allergists

Some highlights of the first century of immunotherapy

Specific immunotherapy with allergen mixes: what is the evidence?

Sub-lingual immunotherapy: World Allergy Organization Position Paper 2009.

Sub-lingual immunotherapy: world allergy organization position paper 2009.

Subcutaneous Immunotherapy and Sublingual Immunotherapy: Comparative Efficacy, Current and Potential Indications, and Warnings--United States Versus Europe

Subcutaneous Injection Immunotherapy for Optimal Effectiveness ⬇️

Subcutaneous immunotherapy

Subcutaneous immunotherapy versus sublingual immunotherapy: which is more effective?

Sublingual immunotherapy tablets as a disease-modifying add-on treatment option to pharmacotherapy for allergic rhinitis and asthma